Center of excellence for cell and gene therapy 

 

Cell and gene therapies are poised to serve a global patient population. However, companies working in this space face challenges in terms of supply chain complexity. The close proximity of manufacturing to patients is key for the success of many cell and gene therapies.

As part of our global network of manufacturing sites, our two facilities in Geleen and Maastricht in the Netherlands help you overcome this challenge. The sites provide flexible capacity and serve customers who need a European manufacturing footprint. 

Our Netherlands sites bring in significant expertise in cell and gene therapy manufacturing. As the CDMO that has supported a number of commercial autologous cell therapy products in Europe, we are committed to using our expertise to help you develop and commercialize your products quickly and efficiently, so that you can ultimately deliver therapy to patients in need of treatment.

2
manufacturing facilities in Geleen & Maastricht
55k
square feet
2005
year established

European cell and gene therapy manufacturing


With world-class expertise and customizable services, our Netherlands sites can help you develop and commercialize your cell and gene therapy products.

Unique Expertise

Through our experience in manufacturing cell therapy products in Europe, we are well-placed to help you in your commercialization journey. Our expertise allows us to offer several release bioassays in-house, shortening your timelines for manufacture, testing and release.  We provide regulatory affairs consultancy and support.

Part of global network

By working with our sites in Geleen and Maastricht, you will have access to our global network of Centers of Excellence which covers three continents.

Bringing your therapy from concept to patient

Our Netherlands sites are fully dedicated to cell and gene therapy. We can support your product at all stages of its lifecycle, from process developments all the way to commercial product manufacturing.